Antibiotic Resistance Solutions Initiative
Providing Critical Support to Combat Antibiotic-Resistant Bacteria
Antibiotic resistance (AR), when bacteria don’t respond to the drugs designed to kill them, threatens to return us to the time when simple infections were often fatal. CDC is committed to protecting Americans and the future of medical innovation from the threat of antibiotic resistance.
In fiscal year 2017, Congress, recognizing the gravity of the threat, appropriated $163 million for CDC to continue to fight AR. With these investments, CDC fortified the AR Solutions Initiative, which has supported the national infrastructure to detect, respond, and prevent resistant infections across healthcare settings, food, and communities since 2016. AR Solutions Initiative activities include putting state and local AR laboratory and epidemiological expertise in every state and making investments in public and private sector innovation to fight AR threats.
CDC has distributed the largest extramural portion of this funding to support all 50 state health departments, the six local health departments, and Puerto Rico.
How did CDC combat AR in your area in 2016? Use the AR Investment Map, a public web app that provides information on CDC’s key AR activities by state.
AR Solutions Initiative Fact Sheets by Topic
View the fact sheets below for more on how the AR Solutions Initiative provides critical support to combat AR.
- Page last reviewed: January 10, 2017
- Page last updated: July 17, 2017
- Content source: